Clover Health Investments Corp(CLOV) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 7:53 PM ET (Korea 9/12 08:53)
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | -0.04 | Insider Own | 22.81% | Shs Outstand | 531.2M | Perf Week | 13.28% |
| Market Cap | 2.56B | Forward P/E | 48.01 | EPS next Y | 79.15% | Insider Trans | -0.84% | Shs Float | 410.0M | Perf Month | 6.17% |
| Enterprise Value | - | PEG | 0.72 | EPS next Q | 0 | Inst Own | 27.62% | Short Float | 5.78% | Perf Quarter | -1.63% |
| Income | -0.02B | P/S | 1.03 | EPS this Y | 55.05% | Inst Trans | 7.11% | Short Ratio | 4.41 | Perf Half Y | 144.67% |
| Sales | 2.48B | P/B | 6.32 | EPS next 5Y | 66.48% | ROA | -2.84% | Short Interest | 23.68M | Perf YTD | 105.11% |
| Book/sh | 0.76 | P/C | - | EPS past 3/5Y | 38.35% 35.85% | ROE | -5.1% | 52W High | -13.77% ($5.59) | Perf Year | 53.5% |
| Cash/sh | - | P/FCF | 34.5 | Sales past 3/5Y | -17.97% 22.9% | ROIC | -4.88% | 52W Low | 205.06% ($1.58) | Perf 3Y | 257.04% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 57.31% | Gross Margin | - | Volatility(W/M) | 4.56% 4.16% | Perf 5Y | -43.89% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | 54.04% | Oper. Margin | -0.74% | ATR (14) | 0.21 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | - | EPS Q/Q | 346.63% | Profit Margin | -0.74% | RSI (14) | 66.33 | Recom | 2 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.5 | Sales Q/Q | 55.6% | SMA20 | 12.17% ($4.3) | Beta | 2.44 | Target Price | $5.38 |
| Payout | - | Debt/Eq | 0 | Earnings | 2026/8/5 | SMA50 | 8.34% ($4.45) | Rel Volume | 0.83 | Prev Close | $4.71 |
| Employees | 724 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 29.53% 2.05% | SMA200 | 51.35% ($3.18) | Avg Volume(3M) | 5.37M | Price | $4.82 |
| IPO | 2020/6/12 | Option/Short | Yes/Yes | Trades | 14287 | Volume | 4,456,380 | Change | 2.34% |
Company
CLOV is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🍀 A US healthcare company that combines Medicare Advantage health insurance with medical data software. It provides Medicare Advantage insurance for seniors while operating a technology-driven model that improves healthcare quality and cost efficiency through a data and software platform that helps physicians with clinical decision-making, making it a health insurer with a tech-forward approach.
Over the past 1 year, on the higher side
14% below its 1-year high.
CLOV has weak earning power
-0.74% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +55.0% this year.
Tap to view numbers
The price looks about right
Trading at - times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 3 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by +257.0% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 27.6%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
HYP 0.03%
XHS 0.02%
HEAL 0.01%
SYZ 0.01%
IHF 0.00%It ranks #4 in the industry
Based on market cap of $3B.
CLOV $3B PER -
UNH $340B PER 24.4
CVS $121B PER 25.0
ELV $91B PER 18.6
FAQ
What kind of company is CLOV?
CLOV belongs to the Healthcare sector and operates in the Healthcare Plans industry.
What is the market cap of CLOV?
The market cap of CLOV is approximately $2.6B, ranking 1,916 within its sector.
What is the 52-week high and low for CLOV?
CLOV has recorded a 52-week high of $5.59 and a low of $1.58.
